tiprankstipranks
TransCode Therapeutics (RNAZ)
NASDAQ:RNAZ
US Market
RNAZ
TransCode Therapeutics
RESEARCH TOOLSreports
Want to see RNAZ full AI Analyst Report?

TransCode Therapeutics (RNAZ) Ratios

437 Followers

TransCode Therapeutics Ratios

RNAZ's free cash flow for Q1 2026 was $0.00. For the 2026 fiscal year, RNAZ's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Mar 24Dec 22
Liquidity Ratios
Current Ratio
 3.11 6.29 2.56 1.28 1.70
Quick Ratio
 3.11 6.29 2.56 1.28 1.70
Cash Ratio
 2.39 5.10 2.10 0.79 1.14
Solvency Ratio
 -1.54 -0.23 -1.74 -5.11 -4.02
Operating Cash Flow Ratio
 -0.93 -5.59 -4.81 -5.18 -3.63
Short-Term Operating Cash Flow Coverage
 0.00 0.00 -348.28 0.00 0.00
Net Current Asset Value
$ 4.11B$ -130.08M$ -2.22M$ 926.56K$ 3.03M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.00 <0.01 0.09 0.00
Debt-to-Equity Ratio
 0.00 0.00 -0.02 0.27 0.00
Debt-to-Capital Ratio
 0.00 0.00 -0.02 0.22 0.00
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.09K 15.71 -3.61 3.15 2.34
Debt Service Coverage Ratio
 -4.62K -5.22K -248.73 -321.53 -0.99
Interest Coverage Ratio
 -4.94K -4.23K -584.07 -347.39 -1.06
Debt to Market Cap
 0.00 0.00 <0.01 0.00 0.00
Interest Debt Per Share
 <0.01 <0.01 0.18 93.37 1.08K
Net Debt to EBITDA
 433.85 0.52 0.36 0.13 0.28
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%0.00%
EBIT Margin
0.00%0.00%0.00%0.00%0.00%
EBITDA Margin
0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin
0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Profit Margin
0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT
48950.45%100.66%100.00%100.00%100.00%
EBT Per EBIT
124.16%123.07%106.99%95.51%94.10%
Return on Assets (ROA)
-12.43%-21.34%-229.69%-358.75%-231.48%
Return on Equity (ROE)
-48101.54%-335.36%829.97%-1130.30%-542.01%
Return on Capital Employed (ROCE)
-0.02%-17.61%-346.27%-1156.48%-575.98%
Return on Invested Capital (ROIC)
-0.02%-17.61%-343.36%-928.50%-575.98%
Return on Tangible Assets
-114.09%-155.05%-229.69%-358.75%-231.48%
Earnings Yield
-345238.89%-735.79%-71.20%-80.16%-0.31%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00 0.00
Payables Turnover
 <0.01 0.00 0.21 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle
 -63.54K 0.00 -1.76K 0.00 0.00
Days of Sales Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 63.54K 0.00 1.76K 0.00 0.00
Operating Cycle
 0.00 0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -5.45K -28.30 -37.45 -3.33K -971.73
Free Cash Flow Per Share
 -5.45K -28.31 -37.51 -3.34K -977.96
CapEx Per Share
 <0.01 <0.01 0.06 6.56 6.22
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.01
Dividend Paid and CapEx Coverage Ratio
 -2.89 -2.93K -612.84 -507.58 -156.19
Capital Expenditure Coverage Ratio
 -749.81K -2.93K -612.84 -507.58 -156.19
Operating Cash Flow Coverage Ratio
 0.00 0.00 -348.28 -40.11 0.00
Operating Cash Flow to Sales Ratio
 0.00 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-88276.49%-414.43%-56.76%-78.28%-0.28%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 >-0.01 -0.14 -1.40 -1.25 -321.59
Price-to-Sales (P/S) Ratio
 0.00 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 0.04 0.46 -11.66 14.10 1.74K
Price-to-Free Cash Flow (P/FCF) Ratio
 >-0.01 -0.24 -1.76 -1.28 -356.09
Price-to-Operating Cash Flow Ratio
 >-0.01 -0.24 -1.76 -1.28 -358.37
Price-to-Earnings Growth (PEG) Ratio
 <0.01 -0.01 0.01 0.01 -0.03
Price-to-Fair Value
 0.04 0.46 -11.66 14.10 1.74K
Enterprise Value Multiple
 433.66 0.38 -1.10 -1.16 -323.12
Enterprise Value
 -12.83B -13.10M 17.76M 20.82M 5.64B
EV to EBITDA
 433.66 0.38 -1.10 -1.16 -323.12
EV to Sales
 0.00 0.00 0.00 0.00 0.00
EV to Free Cash Flow
 2.57 0.67 -1.33 -1.15 -355.77
EV to Operating Cash Flow
 2.57 0.67 -1.33 -1.15 -358.05
Tangible Book Value Per Share
 4.88K -188.06 -5.67 302.49 199.78
Shareholders’ Equity Per Share
 157.61 14.99 -5.67 302.49 199.78
Tax and Other Ratios
Effective Tax Rate
 -0.01 >-0.01 0.00 0.00 0.00
Revenue Per Share
 0.00 0.00 0.00 0.00 0.00
Net Income Per Share
 -21.30K -50.25 -47.05 -3.42K -1.08K
Tax Burden
 489.50 1.01 1.00 1.00 1.00
Interest Burden
 1.34 1.00 1.00 1.00 1.00
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.26 0.56 0.80 0.97 0.90
Currency in USD